Lifecore Biomedical, Inc. \De\ (LFCR) Cost of Revenue (2010 - 2025)

Lifecore Biomedical, Inc. \De\'s Cost of Revenue history runs 16 years deep, the most recent figure standing at $22.5 million for Q2 2025.

• In Q2 2025, Cost of Revenue rose 8.96% year-over-year to $22.5 million; the TTM figure through May 2025 stood at $88.6 million (up 2.5% YoY), while the FY2025 annual figure was $88.6 million, up 2.5% from the prior year.
• Cost of Revenue for Q2 2025 stood at $22.5 million, down from $25.3 million in the prior quarter.
• The five-year high for Cost of Revenue was $66.6 million in Q2 2022, with the low at $14.1 million in Q4 2021.
• The 5-year median for Cost of Revenue is $20.4 million (2023), against an average of $22.5 million.
• The sharpest annual moves came in 2021 and 2022: Cost of Revenue slumped 87.3% in 2021, then jumped 288.71% in 2022.
• Lifecore Biomedical, Inc. \De\'s Cost of Revenue stood at $14.1 million in 2021, then increased by 14.44% to $16.2 million in 2022, then grew by 24.76% to $20.2 million in 2023, then grew by 6.37% to $21.5 million in 2024, then gained by 4.57% to $22.5 million in 2025.
• Business Quant data shows LFCR's Cost of Revenue at $22.5 million in Q2 2025, $25.3 million in Q1 2025, and $21.5 million in Q4 2024.